Ambuja Cements (AMBUJACEM.BO) Earnings Analysis
Ambuja Cements (AMBUJACEM.BO) has no confirmed upcoming earnings date. Last quarter (2026-05-04) it beat with EPS 7.4 INR vs 2.25 INR est (+228.9%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E 22.72.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AMBUJACEM.BO next report earnings?
No confirmed upcoming earnings date is currently scheduled for AMBUJACEM.BO. This page updates as the calendar is published.
AMBUJACEM.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 7.4 INR | 2.25 INR | +228.9% | Beat |
| 2026-01-30 | 0.8 INR | 4.41 INR | -81.9% | Miss |
| 2025-11-03 | 7.2 INR | 2.71 INR | +165.7% | Beat |
| 2025-07-31 | 3.6 INR | 4.72 INR | -23.7% | Miss |
| 2025-01-29 | 7.91 INR | 3.65 INR | +116.7% | Beat |
| 2024-10-28 | 2.48 INR | 2.3 INR | +7.8% | Beat |
| 2024-07-31 | 2.65 INR | 4.68 INR | -43.4% | Miss |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
AMBUJACEM.BO valuation and analyst view
| Trailing P/E | 22.72 |
|---|---|
| Trailing EPS | 18.574 INR |
| Price / book | 1.76 |
| Dividend yield | 0.47% |
| Market cap | 1066.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ambuja Cements (AMBUJACEM.BO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AMBUJACEM.BO. This page updates as the calendar is published.
Did AMBUJACEM.BO beat earnings last quarter?
In its 2026-05-04 report, AMBUJACEM.BO posted EPS of 7.4 INR versus a 2.25 INR estimate — a beat of 228.9%.
What is AMBUJACEM.BO's earnings track record?
Over the last 7 reported quarters with consensus data, AMBUJACEM.BO beat estimates 4 times (57%).
What is AMBUJACEM.BO's current P/E ratio and EPS?
AMBUJACEM.BO trades at a trailing P/E of 22.72 on trailing EPS of 18.573849782860254 INR.
What do analysts rate AMBUJACEM.BO?
AMBUJACEM.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.